Covaxin, India’s first indigenous COVID-19 vaccine, is expected to be available for children by September, Delhi AIIMS chief Dr. Randeep Guleria told a news channel.
In an interview with India Today TV, Guleria said, “Covaxin’s data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.”
In addition, he stated that if Pfizer-BioNTech’s vaccine receives approval in India then that can also be one of the options for children. On June 7, Delhi AIIMS started vaccine clinical trials on kids between the age of 2 to 17.
News Source : India Today
